AKERO THERAPEUTICS INC. - COMMON STOCK

Akero Therapeutics Appoints Yuan Xu to its Board of Directors

26 أبريل 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Akero Therapeutics Announces First Patient Randomized for Dosing in Phase 2b Study of Efruxifermin (EFX) in F2/F3 NASH Patients (HARMONY)

23 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C

22 مارس 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Akero Therapeutics to Announce New Data from an Evaluation of Efruxifermin (EFX) in Cirrhotic NASH (F4) Patients

22 مارس 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results

16 مارس 2021 07:00:03 بحسب Nasdaq GlobeNewswire